• Contact Us
  • Privacy Policy
  • Terms of Use
  • DMCA
Sunday, January 29, 2023
MircoNews.com
  • Home
  • Stock Market News
  • Forex News
  • Economy News
  • Cryptocurrency News
  • Business News
  • Analysis
No Result
View All Result
MircoNews.com
No Result
View All Result

Eli Lilly’s COVID drug bebtelovimab not currently authorized in U.S., says FDA By Reuters

by Andy Hecht
November 30, 2022
in Stock Market News
Reading Time: 1 min read
A A
Alzheimer’s drugmakers seek accelerated FDA review despite U.S. coverage decision By Reuters
ShareShareShareShareShare

Related posts

GSK says tests show antibody drug works against Omicron By Reuters

Rheinmetall eyes boost in munitions output, HIMARS production in Germany By Reuters

January 29, 2023
Short bets on Asian FX rise as Omicron uncertainty grips markets: Reuters poll By Reuters

Rheinmetall moving towards order backlog of 30 billion euros

January 28, 2023

© Reuters. FILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar

(Reuters) – The U.S. Food and Drug Administration said on Wednesday Eli Lilly (NYSE:) and Co’s COVID-19 drug bebtelovimab is not currently authorized for emergency use in the country as it is not expected to neutralize the dominant BQ.1 and BQ.1.1 subvariants of Omicron.

Credit: Source link

ShareTweetSendPinShare
Previous Post

Russian economy shrinks 1.7% in Jan-Sept, but capital investment up By Reuters

Next Post

US stocks rally after Fed chair points to smaller rate increase

Next Post
US stocks rally after Fed chair points to smaller rate increase

US stocks rally after Fed chair points to smaller rate increase

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED NEWS

GSK says tests show antibody drug works against Omicron By Reuters

Rheinmetall eyes boost in munitions output, HIMARS production in Germany By Reuters

6 hours ago
A Strong Dollar, Higher Rates, and Weaker Stocks Will Dominate 2023

The Market Fleeced You Again – and You Probably Do Not Even Realize It

5 days ago
Ethereum (ETH) Approaches All-Time High on the Back of 530% Gain in 2021 By DailyCoin

Ethereum’s Price May Post 10X Gains in the Next Bull Run By CoinEdition

7 days ago
Musk’s $44 billion buyout of Twitter faces U.S. antitrust review -report By Reuters

Twitter faces legal complaint in Germany over anti-Semitic content By Reuters

3 days ago
Telecom Italia close to choosing advisers for KKR deal

U.S. FDA calls for new regulatory framework for use of cannabis compound CBD By Reuters

2 days ago
Dollar Down Over Uncertain Economic Outlook By Investing.com

Dollar eyes gains as jobs data could force rethink of game of chicken against fed By Investing.com

January 5, 2023
Dollar Edges Lower; Sterling Bounces After GDP Surprise By Investing.com

Dollar stays under pressure as sterling, yen rate expectations build By Investing.com

January 24, 2023
Crypto broker Genesis files for Chapter 11 bankruptcy

Crypto broker Genesis files for Chapter 11 bankruptcy

January 20, 2023
Top IMF official to visit Sri Lanka this week to brief about economy’s state By Reuters

Yellen, China’s Liu agree to enhance communication after ‘frank exchange’

January 18, 2023
Top IMF official to visit Sri Lanka this week to brief about economy’s state By Reuters

China fx reserves rise $11 billion to $3.128 trillion in December By Reuters

January 7, 2023
A Strong Dollar, Higher Rates, and Weaker Stocks Will Dominate 2023

S&P 500: What Happens if We Enter a Full-Blown Recession?

January 24, 2023

About Us

mirconews.com is an online news portal that aims to provide the Stock Market News, Forex News, Economy News, Cryptocurrency News, Business News, Analysis and much more stuff like that around the world.

What’s New Here!

  • Bitcoin ‘so bullish’ at $23K as analyst reveals new BTC price metrics By Cointelegraph
  • Rheinmetall eyes boost in munitions output, HIMARS production in Germany By Reuters
  • The problem with Kishida’s ‘new capitalism’ philosophy

Topics to Cover!

  • Analysis (892)
  • Business News (1,688)
  • Cryptocurrency News (1,440)
  • Economy News (1,437)
  • Forex News (1,135)
  • Stock Market News (1,432)

Subscribe Now

Loading
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • DMCA

© 2021 - mirconews.com - All rights reserved!

No Result
View All Result
  • Home
  • Stock Market News
  • Forex News
  • Economy News
  • Cryptocurrency News
  • Business News
  • Analysis

© 2021 - mirconews.com - All rights reserved!